Compare Novavax Inc (NVAX) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Impinj Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Impinj Inc trades at $137.09 (market cap $4.19B). The key difference: Impinj Inc is far larger — about 3.2× Novavax Inc's market cap. Which is the better fit depends on your goals.
| NVAX | PI | |
|---|---|---|
Market Cap | $1.30B | $4.19B |
Sector | Health | Technology |
52-Week High | $11.19 | $241.91 |
52-Week Low | $6.22 | $91.34 |
Enterprise Value | $800.50M | $4.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
